NanoTherapX
PrivateLast Round
Grant
Oct 8, 2024
Total Funding Raised
$18,000
Company Overview
NanoTherapX is a biotechnology company that develops nanotech-powered, plant-based therapies for chronic skin conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Advanced Materials
Business Model
B2B2C
Customer Profile
Hardware Sales, Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NanoTherapX Comps
Public and private peers based on sector, stage, and business model.
NanoTherapX Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 8, 2024 |
NanoTherapX Investors
Notable investors and investment history
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 8, 2024
$18K grant from Biotechnology Industry Research Assistance Council.
NanoTherapX Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NanoTherapX's valuation, stock price, and market status.
